The project, which is an initiative of the Quest Diagnostics Foundation, aims to expand healthcare access in the area, including through no-cost laboratory testing.

The guidelines address items like interpretation of results that may be affected by gender-affirming hormone therapy and improving electronic health record practices.

The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.

The firm currently offers its HerResolve multiomic test for endometriosis that looks at seven biomarkers, including microRNAs ...

The planned trial will investigate Eledon's tegoprubart, a therapy designed to prevent organ rejection in kidney transplantation.

The agency cleared more than a dozen assays and instruments for microbiology, molecular biology, clinical chemistry, and other testing.

Verici Dx said on Wednesday that its Tutivia lab-developed test for acute kidney transplant rejection risk has been approved by the New York State Department of Health (NYSDOH). With the approval ...

NEW YORK – French oncology diagnostics company Spotlight Medical announced on Tuesday that its MyStage Dx assay for breast cancer has received CE marking under Europe's In Vitro Diagnostic Regulation.

The Germany-based company is developing a handheld infectious disease testing platform that does not require electricity.

Last week, readers were most interested in a story about an allegation that Invitae illegally shared patients' genetic data.

The guidelines state that a test must be FDA-approved, personalized, tumor-informed, multiplex, and use PCR-NGS for ctDNA.